Canopy Growth(US:CGC) ZACKS·2024-08-09 14:46分组1 - Canopy Growth Corporation reported a quarterly loss of $0.37 per share, which was worse than the Zacks Consensus Estimate of a loss of $0.31, and compared to a loss of $0.40 per share a year ago, indicating a surprise of -19.35% [1] - The company posted revenues of $48.39 million for the quarter ended June 2024, missing the Zacks Consensus Estimate by 6.61%, and down from $80.95 million in the same quarter last year [2] - Canopy Growth shares have increased by approximately 35.4% since the beginning of the year, outperforming the S&P 500's gain of 11.5% [3] 分组2 - The current consensus EPS estimate for the upcoming quarter is -$0.27 on revenues of $52.49 million, and for the current fiscal year, it is -$1.07 on revenues of $218.28 million [7] - The Medical - Products industry, to which Canopy Growth belongs, is currently ranked in the top 36% of over 250 Zacks industries, suggesting a favorable outlook for stocks in this sector [8]